AGE REVERSAL PILL SHOWS PROMISING RESULTS IN DOGS, HUMAN TRIALS ON THE HORIZON
A groundbreaking study on age reversal, involving a new drug designed to stabilize telomeres—the protective caps on the ends of DNA—has shown remarkable results in dogs.
Zeus, a 12-year-old German Shepherd (equivalent to 80-90 human years), was diagnosed with terminal cancer and underwent surgery. Six months after taking the investigational longevity pill developed by Telomir Pharmaceuticals, Zeus fully recovered, with a body scan confirming he is now cancer-free. This recovery is likely due to stem cell rejuvenation, a mechanism that could be equally effective in humans.
Another elderly dog, Benson, regained his mobility after taking the pill.
Tragically, Dr. Chapman, who pioneered this study, passed away recently.
Human trials are scheduled to begin in 2025, offering hope for significant extensions in healthy lifespans.
Could be huge!
MDB
npub1dd…mfrmf
2024-08-18 17:06:24
Author Public Key
npub1ddxxz2v3zvk0f3krjrww4tn4qsdej496f7wyvkk2wzltx5yptfts6mfrmfPublished at
2024-08-18 17:06:24Event JSON
{
"id": "d04cd053ae74815e96fb134dc244b9accdf03dcf10bed4c95d1b3f50f86b5951",
"pubkey": "6b4c612991132cf4c6c390dceaae75041b9954ba4f9c465aca70beb350815a57",
"created_at": 1724000784,
"kind": 1,
"tags": [],
"content": "AGE REVERSAL PILL SHOWS PROMISING RESULTS IN DOGS, HUMAN TRIALS ON THE HORIZON\n\nA groundbreaking study on age reversal, involving a new drug designed to stabilize telomeres—the protective caps on the ends of DNA—has shown remarkable results in dogs.\n\nZeus, a 12-year-old German Shepherd (equivalent to 80-90 human years), was diagnosed with terminal cancer and underwent surgery. Six months after taking the investigational longevity pill developed by Telomir Pharmaceuticals, Zeus fully recovered, with a body scan confirming he is now cancer-free. This recovery is likely due to stem cell rejuvenation, a mechanism that could be equally effective in humans.\n\nAnother elderly dog, Benson, regained his mobility after taking the pill.\n\nTragically, Dr. Chapman, who pioneered this study, passed away recently. \n\nHuman trials are scheduled to begin in 2025, offering hope for significant extensions in healthy lifespans.\n\nCould be huge!",
"sig": "513883f2f037ee38e3d1470e607bc43c40ef9f2f51ec4017f29e0b2a8359e6ebaeb468672c0bdd5cdff4b260af0ab18e26a7f87ec8f09addd707f35578c1deeb"
}